620 related articles for article (PubMed ID: 11315991)
1. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
Weber K; Goldberg M; Stangassinger M; Erben RG
J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
[TBL] [Abstract][Full Text] [Related]
2. 1 Alpha-hydroxyvitamin D2 and 1 alpha-hydroxyvitamin D3 have anabolic effects on cortical bone, but induce intracortical remodeling at toxic doses in ovariectomized rats.
Weber K; Kaschig C; Erben RG
Bone; 2004 Sep; 35(3):704-10. PubMed ID: 15336607
[TBL] [Abstract][Full Text] [Related]
3. 1alpha-hydroxyvitamin D2 partially dissociates between preservation of cancellous bone mass and effects on calcium homeostasis in ovariectomized rats.
Erben RG; Bante U; Birner H; Stangassinger M
Calcif Tissue Int; 1997 May; 60(5):449-56. PubMed ID: 9115163
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic effects of 1,24,25-trihydroxyvitamin D3 on ovariectomy-induced cancellous bone loss in the rat.
Erben RG; Bante U; Birner H; Stangassinger M
Calcif Tissue Int; 1997 May; 60(5):434-40. PubMed ID: 9115161
[TBL] [Abstract][Full Text] [Related]
5. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet.
Yoshitake K; Yokota K; Kasugai Y; Kagawa M; Sukamoto T; Nakamura T
Bone; 1999 Sep; 25(3):311-9. PubMed ID: 10495135
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of 1alpha,25-dihydroxyvitamin D3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1alpha,25-dihydroxyvitamin D3 on bone.
Erben RG; Bromm S; Stangassinger M
Endocrinology; 1998 Oct; 139(10):4319-28. PubMed ID: 9751515
[TBL] [Abstract][Full Text] [Related]
7. Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3.
Erben RG; Mosekilde L; Thomsen JS; Weber K; Stahr K; Leyshon A; Smith SY; Phipps R
J Bone Miner Res; 2002 Aug; 17(8):1498-511. PubMed ID: 12162504
[TBL] [Abstract][Full Text] [Related]
8. [Effects of 1 alpha(OH)D3 on trabecular and cortical bone in ovariectomized rats].
Xia W; Meng X; Xing X; Hu Y; Liu H; Zhou X; Qiu G; Yang X; Shen V; Wu D; Dempster D; Lindsay R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec; 22(6):543-7. PubMed ID: 12903400
[TBL] [Abstract][Full Text] [Related]
9. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with eldecalcitol (1α, 25-dihydroxy-2β- (3-hydroxypropyloxy) vitamin D3) suppresses bone turnover and leads to prevention of bone loss and bone fragility in ovariectomized rats.
Takeda S; Smith SY; Tamura T; Saito H; Takahashi F; Samadfam R; Haile S; Doyle N; Endo K
Calcif Tissue Int; 2015 Jan; 96(1):45-55. PubMed ID: 25467010
[TBL] [Abstract][Full Text] [Related]
11. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
12. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
13. Short-term prophylaxis against estrogen depletion-induced bone loss with calcitriol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized rats.
Erben RG; Bromm S; Stangassinger M
Osteoporos Int; 1998; 8(1):82-91. PubMed ID: 9692082
[TBL] [Abstract][Full Text] [Related]
14. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
15. Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):1-8. PubMed ID: 16637224
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats.
Erben RG; Weiser H; Sinowatz F; Rambeck WA; Zucker H
Calcif Tissue Int; 1992 Mar; 50(3):228-36. PubMed ID: 1617497
[TBL] [Abstract][Full Text] [Related]
17. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
Ke HZ; Qi H; Crawford DT; Simmons HA; Xu G; Li M; Plum L; Clagett-Dame M; DeLuca HF; Thompson DD; Brown TA
J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
[TBL] [Abstract][Full Text] [Related]
18. Role of vitamin D metabolites in the prevention of the osteopenia induced by ovariectomy in the axial and appendicular skeleton of the rat.
Erben RG; Kohn B; Weiser H; Sinowatz F; Rambeck WA
Z Ernahrungswiss; 1990 Dec; 29(4):229-48. PubMed ID: 2080635
[TBL] [Abstract][Full Text] [Related]
19. Calcium supplementation does not reproduce the pharmacological efficacy of alfacalcidol for the treatment of osteoporosis in rats.
Shiraishi A; Ito M; Hayakawa N; Kubota N; Kubodera N; Ogata E
Calcif Tissue Int; 2006 Mar; 78(3):152-61. PubMed ID: 16525749
[TBL] [Abstract][Full Text] [Related]
20. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
Fanti P; Monier-Faugere MC; Geng Z; Schmidt J; Morris PE; Cohen D; Malluche HH
Osteoporos Int; 1998; 8(3):274-81. PubMed ID: 9797913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
